Assessment of Herpes Zoster Risk Among Recipients of COVID-19 Vaccine.

ABSTRACT:

Importance

Herpes zoster infection after COVID-19 vaccination has been reported in numerous case studies. It is not known whether these cases represent increased reporting or a true increase in risk.

Objective

To assess whether COVID-19 vaccination is associated with an increased risk of herpes zoster infection.

Design, setting, and participants

This cohort study used a self-controlled risk interval (SCRI) design to compare the risk of herpes zoster in a risk interval of 30 days after COVID-19 vaccination or up to the date of the second vaccine dose with a control interval remote from COVID-19 vaccination (defined as 60-90 days after the last recorded vaccination date for each individual, allowing for a 30-day washout period between control and risk intervals). A supp

SUBMITTER: Akpandak I 

PROVIDER: S-EPMC9669817 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature